Literature DB >> 24578575

Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.

Dilek Colak1, Nikica Zaninovic, Michael S Cohen, Zev Rosenwaks, Wang-Yong Yang, Jeannine Gerhardt, Matthew D Disney, Samie R Jaffrey.   

Abstract

Epigenetic gene silencing is seen in several repeat-expansion diseases. In fragile X syndrome, the most common genetic form of mental retardation, a CGG trinucleotide-repeat expansion adjacent to the fragile X mental retardation 1 (FMR1) gene promoter results in its epigenetic silencing. Here, we show that FMR1 silencing is mediated by the FMR1 mRNA. The FMR1 mRNA contains the transcribed CGG-repeat tract as part of the 5' untranslated region, which hybridizes to the complementary CGG-repeat portion of the FMR1 gene to form an RNA·DNA duplex. Disrupting the interaction of the mRNA with the CGG-repeat portion of the FMR1 gene prevents promoter silencing. Thus, our data link trinucleotide-repeat expansion to a form of RNA-directed gene silencing mediated by direct interactions of the trinucleotide-repeat RNA and DNA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24578575      PMCID: PMC4357282          DOI: 10.1126/science.1245831

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer.

Authors:  Vaishali Handa; Tapas Saha; Karen Usdin
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

2.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome.

Authors:  I Oberlé; F Rousseau; D Heitz; C Kretz; D Devys; A Hanauer; J Boué; M F Bertheas; J L Mandel
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

3.  Effect of in vitro promoter methylation and CGG repeat expansion on FMR-1 expression.

Authors:  G Sandberg; M Schalling
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

4.  CGG repeats associated with DNA instability and chromosome fragility form structures that block DNA synthesis in vitro.

Authors:  K Usdin; K J Woodford
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

5.  Quantitative comparison of FMR1 gene expression in normal and premutation alleles.

Authors:  Y Feng; L Lakkis; D Devys; S T Warren
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

6.  Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation.

Authors:  J R Brouwer; E J Mientjes; C E Bakker; I M Nieuwenhuizen; L A Severijnen; H C Van der Linde; D L Nelson; B A Oostra; R Willemsen
Journal:  Exp Cell Res       Date:  2006-10-13       Impact factor: 3.905

7.  Human embryonic stem cell lines with genetic disorders.

Authors:  Y Verlinsky; N Strelchenko; V Kukharenko; S Rechitsky; O Verlinsky; V Galat; A Kuliev
Journal:  Reprod Biomed Online       Date:  2005-01       Impact factor: 3.828

Review 8.  RNA and microRNAs in fragile X mental retardation.

Authors:  Peng Jin; Reid S Alisch; Stephen T Warren
Journal:  Nat Cell Biol       Date:  2004-11       Impact factor: 28.824

9.  A long purine-pyrimidine homopolymer acts as a transcriptional diode.

Authors:  E Grabczyk; M C Fishman
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

Review 10.  DNA unwinding and protein displacement by superfamily 1 and superfamily 2 helicases.

Authors:  Samuel G Mackintosh; Kevin D Raney
Journal:  Nucleic Acids Res       Date:  2006-08-25       Impact factor: 16.971

View more
  139 in total

1.  Defining the role of the CGGBP1 protein in FMR1 gene expression.

Authors:  Martina Goracci; Stella Lanni; Giorgia Mancano; Federica Palumbo; Pietro Chiurazzi; Giovanni Neri; Elisabetta Tabolacci
Journal:  Eur J Hum Genet       Date:  2015-08-26       Impact factor: 4.246

Review 2.  Unique features of long non-coding RNA biogenesis and function.

Authors:  Jeffrey J Quinn; Howard Y Chang
Journal:  Nat Rev Genet       Date:  2016-01       Impact factor: 53.242

Review 3.  The Yin and Yang of R-loop biology.

Authors:  Lorenzo Costantino; Douglas Koshland
Journal:  Curr Opin Cell Biol       Date:  2015-05-15       Impact factor: 8.382

4.  A Toxic RNA Catalyzes the Cellular Synthesis of Its Own Inhibitor, Shunting It to Endogenous Decay Pathways.

Authors:  Raphael I Benhamou; Alicia J Angelbello; Eric T Wang; Matthew D Disney
Journal:  Cell Chem Biol       Date:  2020-01-24       Impact factor: 8.116

Review 5.  RNA-binding proteins and microRNAs in gastrointestinal epithelial homeostasis and diseases.

Authors:  Lan Xiao; Jian-Ying Wang
Journal:  Curr Opin Pharmacol       Date:  2014-07-24       Impact factor: 5.547

Review 6.  Breaking bad: R-loops and genome integrity.

Authors:  Julie Sollier; Karlene A Cimprich
Journal:  Trends Cell Biol       Date:  2015-06-01       Impact factor: 20.808

Review 7.  GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Res       Date:  2014-11-26       Impact factor: 4.939

8.  Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability.

Authors:  Julie Sollier; Caroline Townsend Stork; María L García-Rubio; Renee D Paulsen; Andrés Aguilera; Karlene A Cimprich
Journal:  Mol Cell       Date:  2014-11-26       Impact factor: 17.970

Review 9.  Emerging role of RNA•DNA hybrids in C9orf72-linked neurodegeneration.

Authors:  Jiou Wang; Aaron R Haeusler; Eric A J Simko
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

10.  C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.

Authors:  Elaine Y Liu; Jenny Russ; Kathryn Wu; Donald Neal; Eunran Suh; Anna G McNally; David J Irwin; Vivianna M Van Deerlin; Edward B Lee
Journal:  Acta Neuropathol       Date:  2014-05-08       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.